Given NAFLD's potential for reclassification and temporal microbiome shifts, hybrid designs using Mendelian randomization (e.g., PNPLA3 rs738409 as an instrument) and longitudinal mixed-effects models are needed to establish causality and translate statistical rigor into biologically meaningful insights. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.